Ascent Therapeutics
Ascent Therapeutics offers Pepducins targeting GPCRs on the cell membrane, expanding the GPCR frontier.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Ascent Therapeutics Information
Geographic Data
Address:
City: Cambridge
State: Massachusetts
Zip:
Country: United States
Financial Info
Stage:
series a
Raised Last:
$19M
Raised Total:$19M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Ascent Therapeutics is pioneering a new class of drugs called pepducins. Pepducins are a breakthrough approach to targeting G-protein coupled receptors (GPCRs) on the inside surface of the cell membrane, dramatically expanding the GPCR frontier. GPCRs are critically involved in a wide variety of serious illnesses, including inflammation, cancer, metabolic CNS disorders and cardiovascular disease. Pepducin technology represents an exciting new area of research directed towards a well-validated class of drug targets.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2007 | Series A | 3 | $19M |
HealthCare Ventures Novartis Venture Fund TVM Capital HealthCare Ventures Novartis Venture Fund TVM Capital |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
